Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Sarkis, Albert ^a   Ito, Osamu ^b   Mori, Takefumi ^a,b   Kohzuki, Masahiro ^b   Ito, Sadayoshi ^b   Verbalis, Joseph ^c   Cowley, Allen W ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

20 hydroxyeicosatetraenoic acid; Brattleboro rats; Cytochrome P 450; Epoxyeicosatrienoic acid; Renal hemodynamics

Indexed keywords

1 AMINOBENZOTRIAZOLE; 20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; CYTOCHROME P450 4A; CYTOCHROME P450 INHIBITOR; EPOXYGENASE; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V2 RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; ENZYME ACTIVITY; ENZYME METABOLISM; KIDNEY CELL; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY METABOLISM; KIDNEY MICROSOME; MALE; MICTURITION; NONHUMAN; OSMOLARITY; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; VASOPRESSIN RELEASE;

EID: 27944466804     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00188.2005     Document Type: Article

References (48)

1. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW Jr, and Roman RJ. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68, 2002.
2. Brimble MJ, Balment RJ, Smith CP, Windle RJ, and Forsling ML. Influence of oxytocin on sodium excretion in the anaesthetized Brattleboro rat. J Endocrinol 129: 49-54, 1991.
3. Cambj-Sapunar L, Yu M, Harder DR, and Roman RJ. Contribution of 5-hydroxytryptamine IB receptors and 20-hydroxyeicosatetraenic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34: 1269-1275, 2003.
4. Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, and McGiff JC. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol Regul Integr Comp Physiol 271: R863-R869, 1996.
5. Croft KD, McGiff JC, Sanchez-Mendoza A, and Caroll MA. Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 279: F544-F551, 2000.
6. Escalante B, Erlij D, Falck JR, and McGiff JC. Effect of cytochrome P-450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991.
7. Escalante B, Sacerdoti D, Davidian MM, Laniado-Schwartzman M, and McGiff JC. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 17: 776-779, 1991.
8. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, and Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87: 60-65, 2000.
9. 1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′,5′-monophosphate and theophylline. J Clin Invest 47: 1154-1161, 1968.
10. Gronich JH, Bonventre JV, and Nemenoff RA. Identification and characterization of a hormonally regulated form of phospholipase A2 in rat renal mesangial cells. J Biol Chem 263: 16645-16651, 1988.
11. Hercule HC and Oyekan AO. Cytochrome P-450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole. J Pharmacol Exp Ther 292: 1153-1160, 2000.
12. Hercule HC and Oyekan AO. Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am J Physiol Regul Integr Comp Physiol 279: R2132-R2141, 2000.
13. Hirt DL, Capdevila J, Falck JR, Breyer MD, and Jacobson HR. Cytochrome P-450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. J Clin Invest 84: 1805-1812, 1989.
14. Hoagland KM, Flasch AK, and Roman RJ. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 42: 669-673, 2003.
15. 2 interactions in cortical collecting tubule. I. Depression of sodium transport. Am J Physiol Renal Fluid Electrolyte Physiol 241: F452-F460, 1981.
16. Imig JD, Falck JR, and Inscho EW. Contribution of cytochrome P-450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. Br J Pharmacol 127: 1399-1405, 1999.
17. Imig JD, Navar LG, Roman RJ, Reddy KK, and Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370, 1996.
18. Imig JD, Zou AP, Ortiz de Montellano PR, Sui Z, and Roman RJ. Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am J Physiol Heart Circ Physiol 266: H1879-H1885, 1994.
19. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, and Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R217-R227, 1996.
20. 2 synthesis in the Brattleboro homozygous diabetes insipidus rats. Prostaglandins Leukot Med 22: 101-110, 1986.
21. 20a. Kaide J, Zhang F, Wei Y, Wang W, Gopal VR, Falck JR, Laniado-Schwartzman M, and Nasjletti A. Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction. Hypertension 44: 210-216, 2004.
22. Levere RD, Martasek P, Escalante B, Schwartzman ML, and Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86: 213-219, 1990.
23. Lisurek M and Bernhardt R. Modulation of aldosterone and cortisol synthesis on the molecular level. Mol Cell Endocrinol 215: 149-159, 2004.
24. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136, 1993.
25. Ma YH, Schwartzman ML, and Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 267: R579-R589, 1994.
26. McGiff JC and Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 10: 231-237, 2001.
27. McGiff JC and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol Regul Integr Comp Physiol 277: R607-R623, 1999.
28. Muthalif MM, Karzoun NA, Benter IF, Gaber L, Ljuca F, Uddin MR, Khandekar Z, Estes A, and Malik KU. Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II-induced vascular hyperplasia and hypertension. Hypertension 39: 704-709, 2002.
29. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, and Malik KU. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P-450 metabolites. Hypertension 36: 604-609, 2000.
30. Negro-Vilar A, Snyder GD, Falck JR, Manna S, Chacos N, and Capdevila J. Involvement of eicosanoids in release of oxytocin and vasopressin from the neural lobe of the rat pituitary. Endocrinology 116: 2663-2668, 1985.
31. Nemenoff RA. Vasopressin signaling pathways in vascular smooth muscle. Front Biosci 3: d194-d207, 1998.
32. +-ATPase. J Clin Invest 99: 1224-1230, 1997.
33. Omata IC, Abraham NG, Escalante B, and Schwartzman ML. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 262: F8-F16, 1992.
34. Ominato M, Satoh T, and Katz AI. Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J Membr Biol 152: 235-243, 1996.
35. Oyekan A, Balazy M, and McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol Regul Integr Comp Physiol 273: R293-R300, 1997.
36. Oyekan AO. Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat. Clin Exp Pharmacol Physiol 27: 581-586, 2000.
37. Oyekan AO and McGiff JC. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol Regul Integr Comp Physiol 274: R52-R61, 1998.
38. 2. Prog Lipid Res 20: 605-608, 1981.
39. Quigley R, Baum M, Reddy KM, Griener JC, and Falck JR. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am J Physiol Renal Physiol 278: F949-F953, 2000.
40. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
41. Roman RJ, Maier KG, Sun CW, Harder DR, and Alonso Galicia M. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27: 855-865, 2000.
42. +)ATPase. Nature 314: 620-622, 1985.
43. Stricker EM and Verbalis JG. Interaction of osmotic and volume stimuli in regulation of neurohypophyseal secretion in rats. Am J Physiol Renal Fluid Electrolyte Physiol 250: R267-R275, 1986.
44. Vallotton MB and Wuthrich RP. The regulation of prostaglandins by vasoactive hormones in renal tubular and vascular smooth muscle cells. Agents Actions Suppl 22: 27-35, 1987.
45. Vazquez B, Rios A, and Escalante B. Arachidonic acid metabolism modulates vasopressin induced renal vasoconstriction. Life Sci 56: 1455-1466, 1995.
46. Walker LA, Whorton AR, Smigel M, France R, and Frolich JC. Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol 235: F180-F185, 1978.
47. +-channel activity. Am J Physiol Renal Physiol 270: F822-F832, 1996.
48. Zou AP, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z, and Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol Renal Physiol 266: F275-F282, 1994.